Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:48:50.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T16:20:33.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    No new additions were noted, but a significant section of content related to downloading data formats and selecting study fields has been removed.
    Difference
    14%
    Check dated 2024-11-23T04:44:44.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Several key government health and information websites have been removed from the monitored list.
    Difference
    0.7%
    Check dated 2024-11-15T23:56:46.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new links to health-related resources and providing enhanced options for downloading study data in various formats.
    Difference
    17%
    Check dated 2024-11-08T18:33:04.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.0 to v2.12.1.
    Difference
    0.3%
    Check dated 2024-11-01T10:54:44.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.